Effect of carbon nanofibre structure on the binding of antibodies

Potential biomedical applications for carbon nanofibres include, but are not limited to, biosensors and drug delivery vehicles. For such applications, it is essential to know how carbon nanotubes interact with antibodies and proteins. We report on the successful adsorption of monoclonal CD3 antibodies on two types of carbon nanofibre produced by the same method and having the same average size and shape, but differing in surface structure and chemistry due to dissimilar post-treatments. Binding of proteins to nanofibres is enhanced by poly (L-lysine) (PLL) and improves with increasing disorder and hydrophilicity of the nanofibres' surface. Oxidized and disordered surfaces of pyrolytically stripped nanofibres show improved wetting and attachment of PLL and proteins compared to hydrophobic and well-ordered surfaces of heat-treated nanofibres. These results show that the surface of carbon nanofibres can be tailored for their use in biomedical applications.